Atorvastatin: DH ‘closely monitoring’ situation amid 'supply constraints'

The Department of Health and Social Care (DH) is “closely monitoring” supply issues around atorvastatin, it has said, following “pricing and availability” concerns raised by England’s community pharmacy negotiator.